2017 – A Landmark Year for Indian Science

2017 – A Landmark Year for Indian Science

By Kiran Mazumdar Shaw, CMD,  Biocon 2017 has been an exciting year for science in India. From unheralded incremental innovations to Big Bang headline-grabbing global feats, Indian scientists have done some very important work to push the frontiers of science during the year. India researchers made significant contributions to R&D across a broad spectrum of [...]

A Journey of Endurance

A Journey of Endurance

By Kiran Mazumdar Shaw, CMD, Biocon The approval of our biosimilar Trastuzumab by the U.S. FDA is a vindication of our two-decade-long biologics-led pharmaceutical journey. We had invested ‘ahead of the curve’ in the promising future of targeted biologics at the turn of the millennium. At that time, we had anticipated some of the risks, [...]

Budget Expands Ambit of Clean India

Budget Expands Ambit of Clean India

Finance Minister Arun Jaitley has presented a Budget that boasts of several firsts. It is the first time that the railway and general budgets have been merged and planned and non-planned expenditure classification done away with. I believe the Finance Minister has laid out a very safe budget this year operating with fiscal prudence and [...]

Transforming India into a digital society that is less cash dependent

Transforming India into a digital society that is less cash dependent

As the debate on the pains and gains of India’s move to demonetize high-value currency notes continues to rage, I firmly believe that the digital payments economy is an idea whose time has come. History shows us how money as a ‘medium of exchange’ has evolved over several millennia from cowry shells to gold and [...]